Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Industrial production method of highly glycosylated recombinant human erythrocyte growth stimulating protein

A cell and process technology, applied in the field of biomedicine, can solve the problems of increasing the possibility of unknown virus contamination of products, difficulty in ensuring the uniformity of product quality, and potential safety hazards in clinical medicine. Improved safety and uniformity

Active Publication Date: 2017-01-25
山东丰金生物医药有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Both of these two production methods have the problem of cultivating a batch of products from dozens to hundreds of different containers, and it is difficult to ensure the uniformity of product quality
At the same time, both of these two production methods require the use of bovine serum, which increases the possibility of unknown virus contamination of the product and poses hidden dangers to the safety of clinical medication.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Industrial production method of highly glycosylated recombinant human erythrocyte growth stimulating protein
  • Industrial production method of highly glycosylated recombinant human erythrocyte growth stimulating protein
  • Industrial production method of highly glycosylated recombinant human erythrocyte growth stimulating protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] This embodiment provides a serum-free medium, which includes a serum-free basal medium and additives.

[0040] The serum-free basal medium ratio of the present embodiment is determined like this:

[0041] Resuscitate the seed cells and amplify the culture, prepare the cell suspension, and inoculate them in three serum-free mediums 1, 2, and 3 respectively. The weight ratios of medium 1, 2, and 3 are 9:1, 3:1, respectively. , 1:1 combination medium of Ex-cell302 medium and CP1027 medium. Cultivate at 36+0.2°C, conduct 6-day sugar batch experiment, start from the 4th day of culture, count the cells every day, collect the culture supernatant, centrifuge to remove the cells and freeze them, and use the ELISA method to detect the expression level of the cells. The proportion of the acidic part of the cell expression product was detected by the method of IEF. In the evaluation, the proportion of the acidic part is taken as the primary consideration index. Evaluation result...

Embodiment 2

[0046] This example provides an industrial production method of highly glycosylated recombinant human erythrocyte growth-stimulating protein, using the serum-free medium of Example 1, and adopting a 5L reactor of animal cells for high-density, suspension perfusion culture, including the following step:

[0047] 1. Cell inoculation stage control

[0048] Resuscitate a 20mL CHO seed cell into a shaker flask, subculture and expand every 3 days, until the cell is expanded to 500mL, and the cell is in the logarithmic growth phase (the density is about 3×106cells / mL), inoculate the 500ml seed cell To the serum-free medium in the 5L NBSCELLIGEN310 bioreactor, the stirring speed is 100-200 rpm. The cell density after inoculation was 5.1×10 5 cells / mL, the initial working volume of the reactor was 3L, and the serum-free medium inoculated with CHO cells was obtained.

[0049] 2. Cell growth stage control

[0050] Under the conditions of temperature 36+0.2°C, pH 6.90-7.20, and dissol...

Embodiment 3

[0057] This example provides an industrial production method of highly glycosylated recombinant human erythrocyte growth-stimulating protein, using the serum-free medium of Example 1, adopting high-density, suspension perfusion culture of animal cells in a 30L reactor, including the following steps :

[0058] 1. Cell inoculation stage control

[0059] Resuscitate a 20mL CHO seeded cell into the shake flask, subculture and expand every 3 days, until the cell is expanded to 5000mL, and the cell is in the logarithmic growth phase (the density is 3×10 6 cells / mL), the 5000ml seed cells were inoculated into the serum-free medium in the SartouriusStedium C-Plus30L bioreactor, and the stirring speed was 100-200 rpm. The cell density after inoculation was 6.6×10 5 cells / mL, the initial working volume of the reactor was 30L, and a serum-free medium inoculated with CHO cells was obtained.

[0060] 2. Cell growth stage control

[0061] Under the conditions of temperature 36+0.2°C, pH...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an industrialized production method for high galactosylated modification recombination human erythrocyte growth stimulation protein utilizing serum-free medium used for steadily improving protein expression index of Darbepoetin Alpha. The method comprises the following steps: adopting serum-free medium to cultivate CHO cell strain in a suspending manner in a biological reactor; expressing the Darbepoetin Alpha in high efficiency in the CHO cell. The invention further discloses the serum-free medium adopted by the industrialized production method for high galactosylated modification recombination human erythrocyte growth stimulation protein. The serum-free medium component used for steadily improving protein expression index of Darbepoetin Alpha is utilized; meanwhile, the CHO cell can efficiently and steadily express Darbepoetin Alpha; expression is stable; cultivation method is brief, and is suitable for large scale cultivation.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and relates to an industrial production method of highly glycosylated recombinant human erythrocyte growth-stimulating protein, in particular to a high-glucose high-glucose medium using a serum-free medium that can be used to stably increase the expression of Darbepoetinα The invention relates to an industrialized production method of kylated modified recombinant human erythrocyte growth stimulating protein. Background technique [0002] Erythropoietin (EPO) is a glycoprotein mainly secreted by the kidney, with a molecular weight of about 34kD. It is the main hormone regulating erythroid hematopoiesis in the human body. Binding, stimulating the proliferation, differentiation and maturation of erythroid progenitor cells, including erythroid burst colony-forming units (BFU-E), erythroid colony-forming units (CFU-E) and proerythroid cells. Impaired renal function leads to abnormal secretion of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12P21/02
Inventor 王征谭靖伟徐云霞唐瑶
Owner 山东丰金生物医药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com